跳至主要内容
临床试验/CTRI/2017/12/010888
CTRI/2017/12/010888已完成未知

A Double Blind Placebo Controlled RandomizedClinical Study to Evaluate The Efficacy Of DRF/Ay/4024-A Polyherbal Ayurvedic Formulation in Obesity

Dabur India Limited0 个研究点目标入组 180 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Obese patients of either sex with BMI 30 to 50 kg/m2 in the age group 18-
  • 2. Willingness to sign informed consent and to come for regular follow- up
  • examinations as & when required.

排除标准

  • 1. Patients with serious systemic ailments, like Uncontrolled Hypertension, OM,
  • 2. Patients with endocrine obesity, i.e., obesity associated with Cushing
  • Syndrome, thyroid dysfunction etc.
  • 3. Pregnant or lactating females and females who are planning to get conceived in
  • near future.
  • 4. Patients with renal or liver dysfunction.
  • 5. Patients not willing to sign informed consent
  • 6. Patients not willing to come for follow-up when required
  • 7. Patients on steroids or any other chronic medication ( >60 days) for any serious
  • systemic disease.

研究者

相似试验